RCGP Curriculum - 15.8 Respiratory Problems
This section of our curriculum guide refers to statement 15.8, Respiratory Problems, produced by the... Read more
GPs were taking too long to refer patients with dementia to secondary care, Newcastle GP Dr Louise Robinson, who has researched dementia and ageing at Newcastle University, told the annual Primary Care Neurology Society Conference in Birmingham last week.
'GPs are the first point of medical contact for dementia patients but they take, on average, 18-30 months to make a diagnosis of dementia,' she said.
'The delay in diagnosing dementia can, in some cases, take up to four years.'
Research has shown that 40 per cent of GPs are reluctant to diagnose dementia early, with the majority not using the mini mental state examination (MMSE), said Dr Robinson.
'This may be down to a variation in skills among GPs, a lack of specialist mental health services or a tendency for preferring watchful waiting,' she said.
'It is not for GPs to decide when to tell patients they have dementia. Patients want to know as soon as possible so that they can have a say in the matter.'
She said early diagnosis allowed patients and families to adjust both emotionally and practically to the illness. Patients would be more aware and able to influence their care.
What do you think? Comment below or email us at healthcare.republic@haymarket.com
Quick search - use * for an abbreviated search, eg nico*
This section of our curriculum guide refers to statement 15.8, Respiratory Problems, produced by the... Read more
This section of our curriculum guide refers to statement 15.10, Skin Problems, produced by the Royal... Read more
This section of our curriculum guide refers to statement 15.6, Metabolic Problems, produced by the R... Read more
Contributed by Dr Naila Arebi, consultant gastroenterologist, St Mark's Hospital, Harrow, and The Lo... Read more
Contributed by Dr Alan McOwan, lead clinician, Victoria Clinic for HIV and Sexual Health, London. Read more
A non-daily, low oestrogen contraceptive utilising a vaginal delivery system. Read more
Nordic Pharma has launched Siklos (hydroxycarbamide) for the prevention of recurrent painful vaso-oc... Read more
Schering-Plough has launched Bridion (sugammadex) for the reversal of neuromuscular blockade induced... Read more
Comments
Only registered users may comment. Log in now or register for a free account.